As the Centers for Medicare & Medicaid Services (CMS) prepares to roll out the second round of "medically unlikely" edits (MUEs) on April 1, pathology groups are advocating the creation of a panel that would guide the complex project. The panel would aim to bring transparency to the process of developing and implementing MUEs while helping to ensure that the edits will be based on appropriate evidence.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

April 2007 - Table of Contents

LIR April 2007 (full PDF issue)

Financial Benchmarks at 10 Major Labs: Quest and LabCorp See Gains in Revenue and Profit Per Billable Test

Aetna’s Lab Is Quest, LabCorp Takes a Hit

Kennedy to Fast Track New Bill to Regulate Lab Tests

Decatur Memorial Hospital Laboratory Enters the Molecular World

Benchmarking the Major Labs

Genova Diagnostics Buys Texas Reference Lab

Beckman Coulter to Buy Biosite for $1.55 billion

CMS Continues Rolling Out Medically Unlikely Edits

MDS Completes $615M Purchase of Molecular Devices

Lab Stocks Rise 3% Led by Orchid and Clarient

Biggest Challenges for AP Practices